Smith & Nephew plc has followed last year’s launch of PICO in Europe, Canada, and Australia by announcing that its pocket-sized PICO single use Negative Pressure Wound Therapy (NPWT) system has now received FDA clearance.
Wound Management
Smith & Nephew Spins Out Biologics Business
Smith & Nephew is to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to create a US-based joint venture with the goal of advancing its Biologics and Clinical Therapy solutions.
Delayed NHS Spending Sees PuriCore’s UK Endoscopy And Laboratory Business Drop
PuriCore’s UK endoscopy and laboratory business decreased 13%, while Vashe Wound Therapy sales grew 51% increase for the three quarters over the same period in 2010.
Systagenix Adds Two Members to Board of Directors
Systagenix Wound Management has announced the appointments of Oern Stuge and Jack Wilkens as members of the company’s Board of Directors.
Smith and Nephew Quarterly Results: Efficiency Improvements in Orthopaedics Group are Key
Smith & Nephew results for the third quarter show revenue increase, margin decrease and $150m cost reduction plans.
Antimicrobial dressing for severe and high exudate wounds
A new antimicrobial dressing suitable for severe and high exudate wounds has been launched by Synergy Health
Smith & Nephew Announces European Launch of ACTICOAT Flex
Smith & Nephew’s Advanced Wound Management division, announce the European launch of ACTICOAT™ Flex 3 and ACTICOAT™ Flex 7, to expand the ACTICOAT portfolio.
KCI Appoints Michael Genau to New Global Leadership Position To Expand Current Wound Therapy Division
Kinetic Concepts, Inc. announced today that Michael Genau has joined the Company in the newly formed position of Global President, Wound Therapy.
Wound Management Technologies, Inc. Announces That It Has Reached an Agreement to Acquire BioPharma Management Technologies, Inc.
Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., announced today that it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc.
Prospective Evaluation Finds High Levels of Satisfaction with ConvaTec Moldable Skin Barrier
Enterostomal therapy nurses and people living with an ostomy reported very high levels of satisfaction with a new moldable skin barrier pioneered by ConvaTec Ostomy Care, according to results from a prospective evaluation published this month.